Cargando…

Anti-TIF1gamma Antibody-Positive Dermatomyositis Associated with Myelodysplastic Syndrome: Response to Treatment

Dermatomyositis (DM) classically presents as a dyad of typical cutaneous findings and varying degrees of proximal muscle weakness. Interestingly, the development of DM may signal underlying malignancy, and numerous myositis-specific autoantibodies have been associated with this paraneoplastic phenom...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lerman, Irina, Richardson, Christopher T
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cureus 2019
Materias:	Rheumatology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6825482/ https://www.ncbi.nlm.nih.gov/pubmed/31723534 http://dx.doi.org/10.7759/cureus.5775

Ejemplares similares

AB019. Response to tofacitinib in a case of refractory TIF-1 positive amyopathic dermatomyositis with arthritis
por: Jasmine, Sion Ward, et al.
Publicado: (2021)

Dermatomyositis with positive anti‐TIF1 gamma antibodies in an adult female: A case report
por: Adhikari, Krishna, et al.
Publicado: (2023)

A unique case of dermatomyositis associated with anti-TIF1γ antibody and chondrosarcoma
por: Dziwis, Jennifer, et al.
Publicado: (2019)

Pseudogout: An Autoimmune Paraneoplastic Manifestation of Myelodysplastic Syndrome
por: Iqbal, Shumaila M, et al.
Publicado: (2018)

Coexisting TIF1γ-positive Primary Pulmonary Lymphoepithelioma-like Carcinoma and Anti-TIF1γ Antibody-positive Dermatomyositis
por: Nakanishi, Yu, et al.
Publicado: (2020)

Clinical Characteristics of Anti-TIF-1γ Antibody-Positive Dermatomyositis Associated with Malignancy
por: Harada, Yumi, et al.
Publicado: (2022)

Paraneoplastic Anti-Tif1-gamma Autoantibody-positive Dermatomyositis as Clinical Presentation of Hepatocellular Carcinoma Recurrence
por: Ferronato, Marco, et al.
Publicado: (2023)

A Case of Dermatomyositis Causing Cryptogenic Organizing Pneumonia
por: Miskoff, Jeffrey A, et al.
Publicado: (2019)

Acute Respiratory Distress Syndrome Requiring Extracorporeal Membrane Oxygenation as the Initial Presentation of Anti-neutrophillic Cytoplasmic Auto-antibody Positive Vasculitis
por: Kundu, Suhali, et al.
Publicado: (2019)

A Rare Case of Adult-onset Still’s Disease with Anti-Ro Antibody Positive
por: Sodavarapu, Soujanya, et al.
Publicado: (2019)

Analysis of human total antibody repertoires in TIF1γ autoantibody positive dermatomyositis
por: Megremis, Spyridon, et al.
Publicado: (2021)

Marked Improvement of Anti-TIF1-γ Antibody-Positive Dermatomyositis After Chemoradiotherapy to Relevant Nasopharyngeal Cancer
por: Tomita, Natsuo, et al.
Publicado: (2021)

Anti–Cytosolic 5′‐Nucleotidase 1A Autoantibodies Are Absent in Juvenile Dermatomyositis
por: Rietveld, Anke, et al.
Publicado: (2021)

Diagnostic Utility of Minor Salivary Gland Biopsy for Primary Sjögren Syndrome in Patients With Negative Anti-SSA Antibodies
por: Goel, Rohit R, et al.
Publicado: (2023)

Pitfalls in the Diagnosis and Management of an Unusual Presentation of Clinically Amyopathic Dermatomyositis: A Case Report Written With the Assistance of ChatGPT
por: Jansz, Jacqueline, et al.
Publicado: (2023)

Anti‐TIF1γ antibody‐positive dermatomyositis associated with durvalumab administration in a patient with lung and oesophageal cancers
por: Imai, Ryosuke, et al.
Publicado: (2021)

1. TIF1-γ associated dermatomyositis
por: Waller, Rosemary, et al.
Publicado: (2019)

Anti-transcription intermediary factor 1 gamma (TIF1γ) antibody-positive dermatomyositis associated with ascending colon cancer: a case report and review of the literature
por: Ono, Ryohei, et al.
Publicado: (2021)

ELISA, protein immunoprecipitation and line blot assays for anti-TIF1-gamma autoantibody detection in cancer-associated dermatomyositis
por: Selickaja, Sandra, et al.
Publicado: (2022)

Comparison of Children With Onset of Juvenile Dermatomyositis Symptoms Before or After Their Fifth Birthday in a UK and Ireland Juvenile Dermatomyositis Cohort Study
por: Martin, N, et al.
Publicado: (2012)

Efficacy and Safety of Cyclophosphamide Treatment in Severe Juvenile Dermatomyositis Shown by Marginal Structural Modeling
por: Deakin, Claire T., et al.
Publicado: (2018)

Therapeutic Effects of Treating COVID-19 Vaccine-Induced Anti-TIF1-γ-Positive Dermatomyositis
por: Wu, Chih-Feng, et al.
Publicado: (2023)

Meta-analysis of anti-Saccharomyces cerevisiae antibodies as diagnostic markers of Behçet’s disease with gastrointestinal involvement
por: Cheng, Linlin, et al.
Publicado: (2020)

Anti-Signal Recognition Particle Antibody-Associated Severe Interstitial Lung Disease Requiring Lung Transplantation
por: Qureshi, Anam, et al.
Publicado: (2020)

Palmoplantar keratoderma as the preceding cutaneous manifestation of juvenile-onset dermatomyositis
por: Patra, Pratap Kumar, et al.
Publicado: (2022)

Endothelial and Inflammation Biomarker Profiles at Diagnosis Reflecting Clinical Heterogeneity and Serving as a Prognostic Tool for Treatment Response in Two Independent Cohorts of Patients With Juvenile Dermatomyositis
por: Wienke, Judith, et al.
Publicado: (2020)

Myositis-specific Autoantibodies Reacting to Both Tif1gamma and Mi-2 in a Patient with Juvenile Dermatomyositis
por: TAKEZAKI, Daiki, et al.
Publicado: (2020)

Comparison of the Utility and Validity of Three Scoring Tools to Measure Skin Involvement in Patients With Juvenile Dermatomyositis
por: Campanilho‐Marques, Raquel, et al.
Publicado: (2016)

Muscle Biopsy Findings in Combination With Myositis‐Specific Autoantibodies Aid Prediction of Outcomes in Juvenile Dermatomyositis
por: Deakin, Claire T., et al.
Publicado: (2016)

Clinical characteristics of infective endocarditis in patients with antineutrophil cytoplasmic antibody or antiphospholipid antibody: a retrospective study in Shanghai
por: Zhou, Zhuochao, et al.
Publicado: (2020)

Vapour, gas, dust and fume occupational exposures in male patients with rheumatoid arthritis resident in Cornwall (UK) and their association with rheumatoid factor and anti-cyclic protein antibodies: a retrospective clinical study
por: Murphy, Dan, et al.
Publicado: (2018)

A Pediatric Case of Granulomatous Myositis and Response to Treatment
por: Abdul-Aziz, Rabheh, et al.
Publicado: (2021)

The digestive system involvement of antiphospholipid syndrome: pathophysiology, clinical characteristics, and treatment strategies
por: Zhang, Jin, et al.
Publicado: (2021)

Associations between antinuclear antibody staining patterns and clinical features of systemic lupus erythematosus: analysis of a regional Swedish register
por: Frodlund, Martina, et al.
Publicado: (2013)

Anti-TIF1γ antibody predicted malignancy of thymic tumor with dermatomyositis as an “autoimmune tumor marker”: A case report
por: Karino, Kohei, et al.
Publicado: (2018)

Autoantibodies to transcription intermediary factor (TIF)1β associated with dermatomyositis
por: Satoh, Minoru, et al.
Publicado: (2012)

Prominent dyspigmentation in a patient with dermatomyositis and TIF1-γ autoantibodies
por: Gutierrez, Daniel, et al.
Publicado: (2022)

A Case Report of Anti-phospholipid Syndrome With Lower Extremity Arterial Thrombosis That Didn’t Respond to Heparin and Direct Oral Anticoagulation: Ultimately, the Patient Agreed to Oral Warfarin
por: Abdulrahman, Zeinab A, et al.
Publicado: (2022)

NanoString technology distinguishes anti‐TIF‐1γ(+) from anti‐Mi‐2(+) dermatomyositis patients
por: Preusse, Corinna, et al.
Publicado: (2021)

Study protocol: Comparison of the effect of treatment with Nonsteroidal anti-inflammatory drugs added to anti-tumour necrosis factor a therapy versus anti-tumour necrosis factor a therapy alone on progression of Structural damage in the spine over two years in patients with ankyLosing spondylitis (CONSUL) – an open-label randomized controlled multicenter trial
por: Proft, Fabian, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_dvdogup56dagoni3pb9eputc6k